DEA Archived Press Releases

Press Releases before January 20, 2025
702 Results - Showing 351 to 360
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on October 27

El PASO, Texas – After collecting a total of more than 9.9 million pounds (nearly 5,000 tons) of expired, unused and unwanted prescription medications during 15 previous events over the past eight years, the Drug Enforcement Administration expects to reach a total of 10 million pounds collected following the upcoming...
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on October 27

WASHINGTON – After collecting a total of more than 9.9 million pounds (nearly 5,000 tons) of expired, unused and unwanted prescription medications during 15 previous events over the past eight years, the Drug Enforcement Administration expects to reach a total of 10 million pounds collected following the upcoming fall 2018...
PRESS RELEASE

DEA to kick off annual Red Ribbon Campaign

WASHINGTON – The United States Drug Enforcement Administration is gearing up to kick off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort, which launches October 23. The National Red Ribbon Campaign began after drug traffickers in Mexico tortured and brutally murdered Special Agent Enrique “Kiki” Camarena in...
PRESS RELEASE

Justice, Treasury, and State Departments announce coordinated enforcement efforts against Cartel Jalisco Nueva Generacion

WASHINGTON – The United States of America, through its Departments of Justice, Treasury, and State announced today a series of measures to target and dismantle the Cartel Jalisco Nueva Generacion (CJNG) – one of the largest, most dangerous drug cartels currently operating in Mexico. These measures include the unsealing of...
PRESS RELEASE

DEA Acting Administrator underscores the importance of drug enforcement efforts to combat opioid epidemic

SALT LAKE CITY – DEA Acting Administrator Uttam Dhillon today highlighted the significance of law enforcement as part of a successful, comprehensive solution to the opioid epidemic, stressing efforts aimed at those supplying communities with deadly, addictive drugs. Acting Administrator Dhillon delivered remarks to hundreds of medical practitioners, drug treatment...
PRESS RELEASE

Wife of Former U.S. Customs and Border Protection Officer in El Paso extradited to the United States from Mexico

EL PASO, Texas -- An El Paso woman who fled the country prior to sentencing on federal drug trafficking and bribery charges in 2010 has been extradited to the United States from Mexico, announced U.S. Attorney for the Western District of Texas John F. Bash; Drug Enforcement Administration El Paso...
PRESS RELEASE

DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions

WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...
PRESS RELEASE

Two Afghan heroin traffickers sentenced in Manhattan federal court for conspiring to import heroin into the United States

NEW YORK – Raymond P. Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Special Operations Division, along with Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced that Lajbar Lajaward Khan, aka “Haji Lajaward,” and Amal Said Said Alam Shah, aka...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...